HERBERT EDWARD KAUFMAN, MD
Osteopathic Medicine at Gravier St, New Orleans, LA
License number
Louisiana 04025R
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2020 Gravier St SUITE B, New Orleans, LA 70112
Phone
(504) 412-1211
(504) 412-1860
(504) 412-1860
Professional information
Herbert Edward Kaufman, New Orleans LA
Specialties:
Ophthalmologist
Address:
2020 Gravier St, New Orleans, LA 70112
Education:
Harvard Medical School - Doctor of Medicine
National Institutes of Health-Clinical Center - Residency - Ophthalmology
National Institutes of Health-Clinical Center - Residency - Ophthalmology
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Dr. Herbert E Kaufman, New Orleans LA - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
2020 Gravier St STE B, New Orleans 70112
(504) 412-1200 (Phone), (504) 412-1321 (Fax)
(504) 412-1200 (Phone), (504) 412-1321 (Fax)
Certifications:
Ophthalmology, 1962
Awards:
Healthgrades Honor Roll
Languages:
English, Chinese
Education:
Medical School
Harvard Medical School
Massachusetts General Hospital
Natl Inst Hlth
Massachusetts Eye and Ear Infirmary
Harvard Medical School
Massachusetts General Hospital
Natl Inst Hlth
Massachusetts Eye and Ear Infirmary
Use Of Cox-2 Inhibitors To Prevent Recurrences Of Herpesvirus Infections
US Patent:
2003019, Oct 16, 2003
Filed:
Apr 15, 2002
Appl. No.:
10/122666
Inventors:
Herbert Kaufman - New Orleans LA, US
Bryan Gebhardt - New Orleans LA, US
Emily Varnell - New Orleans LA, US
Bryan Gebhardt - New Orleans LA, US
Emily Varnell - New Orleans LA, US
International Classification:
A61K031/415, A61K031/365
US Classification:
514/406000, 514/473000
Abstract:
Selective inhibitors for COX-2 were discovered to prevent the reactivation of viruses that cause latent infections such as herpes simplex virus (HSV-1 and HSV-2). Using mice with a latent infection of HSV, which is subject to reactivation when heat-stressed, a selective COX-2 inhibitor (celecoxib) was shown to significantly suppress viral reactivation in the eye when the inhibitor was administered either by intraperitoneal injection or orally. Acetylsalicylic acid, a nonspecific cyclooxygenase inhibitor, was also found to suppress viral reactivation in this heat-stress mouse model. The COX-2 specific inhibitor, celecoxib, was more effective in preventing viral recurrence than was the nonspecific cyclooxygenase inhibitor aspirin. The use of selective inhibitors of COX-2 to inhibit the recurrence of latent viral infections will be more effective and have fewer side effects than the nonspecific inhibitors. In addition, selective inhibitors of COX-2 can be combined with other known antiviral compounds.
Eye Treatment Suspension
US Patent:
4923699, May 8, 1990
Filed:
Jun 3, 1988
Appl. No.:
7/201933
Inventors:
Herbert E. Kaufman - New Orleans LA
International Classification:
A61M 3100
US Classification:
424427
Abstract:
An ophthalmic treatment system is provided which includes three-dimensional particles of bioerodible material suspended in a liquid carrier or ointment carrier having a pH acceptable to the eye. The particles are at least 0. 5 mm in greatest dimension and are not greater than 0. 4 mm to 0. 7 mm in smallest dimension when disposed in the ocular environment. The treatment system provides reliable, prolonged continuous treatment without irritating the eye.
Artificial Tear Suspension
US Patent:
4923700, May 8, 1990
Filed:
Jun 3, 1988
Appl. No.:
7/201929
Inventors:
Herbert E. Kaufman - New Orleans LA
International Classification:
A61M 3100
US Classification:
424427
Abstract:
An artificial tear suspension system is provided which includes bioerodible mucin-type particles, lipid-type material and aqueous-type material. The bioerodible mucin-type particles are suspended in either the lipid-type material or the aqueous-type material or both. The system provides all of the components of the natural tear film layers, and thus when administered to the eye provides an effective tear film which mimics the natural tear film.
Method, Device, And System For Delivery Of Therapeutic Agents To The Eye
US Patent:
8216603, Jul 10, 2012
Filed:
May 4, 2007
Appl. No.:
12/226963
Inventors:
Herbert Edward Kaufman - New Orleans LA, US
International Classification:
A61F 2/00
US Classification:
424428, 514912
Abstract:
A method, device, and system for easier, consistent, and comfortable delivery of therapeutic agents to the front of the eye.
Drug Delivery System
US Patent:
4882150, Nov 21, 1989
Filed:
May 1, 1989
Appl. No.:
7/345170
Inventors:
Herbert E. Kaufman - New Orleans LA
International Classification:
A61K 922
US Classification:
424428
Abstract:
An ophthalmic drug delivery system is provided which includes at least one particle of bioerodible material, and a liquid or ointment carrier which includes ophthalmic drug to be delivered to the ocular area. A process of making the system and a method of treatment are also provided.
Trephine And Method
US Patent:
4763651, Aug 16, 1988
Filed:
Jan 14, 1986
Appl. No.:
6/818737
Inventors:
Herbert E. Kaufman - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61B 1732
US Classification:
128310
Abstract:
A trephine for cutting a groove in the cornea of an eye comprising a fixation member and a shaft having first and second blades mounted thereon. The fixation member includes a bearing, and the shaft is receivable within the bearing. The fixation member can be affixed to the eye, and the shaft, when received in the bearing, is rotatable in the bearing so that the blades can make cuts in the cornea. By making cuts in the cornea which intersect, a segment of the cornea can be removed to provide the groove.
Trephine And Method
US Patent:
4750491, Jun 14, 1988
Filed:
Nov 8, 1984
Appl. No.:
6/670396
Inventors:
Herbert E. Kaufman - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Marguerite B. McDonald - New Orleans LA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
A61B 1732
US Classification:
128305
Abstract:
A trephine for cutting a groove in the cornea of an eye comprising a fixation member and first and second shafts having blades mounted thereon. The fixation member includes a bearing, and the shafts are sequentially receivable within the bearing. The fixation member can be affixed to the eye, and the shafts, when received in the bearing, are rotatable in the bearing so that the blades carried by the shafts can make cuts in the cornea. By making cuts in the cornea which intersect, a segment of the cornea can be removed to provide the groove.
Lens Storage System
US Patent:
4860885, Aug 29, 1989
Filed:
Apr 29, 1988
Appl. No.:
7/187840
Inventors:
Herbert E. Kaufman - New Orleans LA
Patricia M. Knight - Laguna Niguel CA
Shelley Buchen - Irvine CA
Patricia M. Knight - Laguna Niguel CA
Shelley Buchen - Irvine CA
Assignee:
Allergan, Inc. - Irvine CA
International Classification:
B65D 8122
US Classification:
206 51
Abstract:
A system useful for holding a lens device is disclosed and comprises: a chamber having a hollow interior space therein; a seal element capable of being placed in association with said chamber to substantially seal said interior space from the environment surrounding said chamber; a carrier assembly sized and adapted to carry a lens device and to be placed in said interior space; and an absorbent member located in said interior space and capable of carrying a material which is released into said interior space over a period of time.